NDC properties for NDC 9 0069-1311
NDC item 00069131101
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-01 |
| NDC Item | 00069131101 |
| packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
NDC item 00069131104
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-04 |
| NDC Item | 00069131104 |
| packaging | 4 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-04) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
NDC item 00069131110
| NDC 9 | 0069-1311 |
|---|---|
| NDC 10 | 0069-1311-10 |
| NDC Item | 00069131110 |
| packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (0069-1311-10) / 1 mL in 1 VIAL, MULTI-DOSE (0069-1311-01) |
| BLA | BLA125545 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-11-09 |
| Marketing status | ACTIVE |
NDC item 59353012001
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-01 |
| NDC Item | 59353012001 |
| packaging | 1 mL in 1 VIAL, MULTI-DOSE |
| BLA | BLA125545 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |
NDC item 59353012010
| NDC 9 | 59353-120 |
|---|---|
| NDC 10 | 59353-120-10 |
| NDC Item | 59353012010 |
| packaging | 10 VIAL, MULTI-DOSE in 1 CARTON (59353-120-10) / 1 mL in 1 VIAL, MULTI-DOSE (59353-120-01) |
| BLA | BLA125545 |
| Labeler | Vifor (International) Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2020-09-11 |
| Marketing status | ACTIVE |